Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | NOX1 | Q9Y5S8 | 2/20 | 0.41 |
| ▸ | BCHE | P06276 | 8/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.35 |
| ▸ | ACHE | P22303 | 2/20 | 0.35 |
| ▸ | KDM1A | O60341 | 2/20 | 0.35 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.34 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.34 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.34 |
| ▸ | HTR2C | P28335 | 2/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.34 |
| ▸ | DRD3 | P35462 | 2/20 | 0.34 |
| ▸ | HTR2B | P41595 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12281545 | 0.91 | MAOA (0.41) | MAOANOX1BCHEKMT2APTGS1 | |
| SCHEMBL13353446 | 0.84 | HDAC6 (0.37) | MAOANOX1BCHEKMT2ACYP1A2 | |
| SCHEMBL12333548 | 0.84 | BCHE (0.38) | MAOANOX1BCHEKMT2ACYP1A2 | |
| SCHEMBL2483549 | 0.83 | MAOA (0.37) | MAOANOX1BCHEKMT2ACYP1A2 | |
| SCHEMBL12333549 | 0.83 | MAOA (0.37) | MAOANOX1BCHEKMT2ACYP1A2 | |
| SCHEMBL12333544 | 0.82 | KMT2A (0.43) | KMT2ACYP1A2CYP2D6SLC6A2SLC6A4 | |
| SCHEMBL12165686 | 0.82 | KMT2A (0.41) | MAOANOX1KMT2ACYP1A2CYP2D6 | |
| SCHEMBL15434752 | 0.81 | KMT2A (0.42) | KMT2ACYP1A2CYP2D6SLC6A2SLC6A4 | |
| SCHEMBL20549019 | 0.80 | KDM1A (0.42) | MAOABCHEKMT2ACYP1A2CYP2D6 | |
| SCHEMBL16890747 | 0.79 | HDAC6 (0.34) | MAOANOX1BCHEHDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11264575-B2 | Compounds for electronic devices | MERCK PATENT GMBH (DE) | 2022-03-01 | — | — | US | disclosed |
| US-10008673-B2 | Compounds for electronic devices | MERCK PATENT GMBH (DE) | 2018-06-26 | — | — | US | disclosed |
| US-20170155062-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2017-06-01 | — | — | US | disclosed |
| US-20120319052-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2012-12-20 | — | — | US | disclosed |
| WO-2011107186-A2 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2011-09-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11264575-B2 | Compounds for electronic devices | CYP2C19, CYP2C18, CYP1B1 | MAOA 654/4885NOX1 236/4885BCHE 2116/4885 |
| US-20170155062-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | CYP1B1, CYP1A1, CYP2E1 | MAOA 457/4885NOX1 247/4885BCHE 1391/4885 |
| US-10008673-B2 | Compounds for electronic devices | CYP1B1, CYP1A1, CYP2E1 | MAOA 457/4885NOX1 247/4885BCHE 1391/4885 |
| US-20120319052-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | CYP1B1, CYP1A1, CYP2E1 | MAOA 457/4885NOX1 247/4885BCHE 1391/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.